DNA-PKcs-dependent NHEJ pathway supports the progression of topoisomerase II poison-induced chromosome aberrant cells

Environmental and Molecular Mutagenesis

Volumn 53, Issue 8, 2012, Pages 608-618

  Elguero, Maria Eugenia ^a   de Campos Nebel, Marcelo ^a   González Cid, Marcela ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Chinese hamster cell lines; Chromosome integrity; Double strand break repair; Etoposide; Idarubicin; Micronucleus

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DOUBLE STRANDED DNA; ETOPOSIDE; IDARUBICIN; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL SURVIVAL; CHROMATID EXCHANGE; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; HOMOLOGOUS RECOMBINATION; INTERPHASE; MICRONUCLEUS; MITOSIS; NONHUMAN;

ANIMALS; CELL CYCLE; CELL LINE; CHO CELLS; CHROMOSOME ABERRATIONS; CRICETINAE; CRICETULUS; DNA BREAKS, DOUBLE-STRANDED; DNA TOPOISOMERASES, TYPE II; ETOPOSIDE; G1 PHASE; G2 PHASE; IDARUBICIN; MICRONUCLEI, CHROMOSOME-DEFECTIVE;

EID: 84867362456     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21729     Document Type: Article

References (55)

1. Abaji C, Cousineau I, Belmaaza A. 2005. BRCA2 regulates homologous recombination in response to DNA damage: Implications for genome stability and carcinogenesis. Cancer Res 65: 4117-4125.
2. Abbott DW, Freeman ML, Holt JT. 1998. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst 90: 978-985.
3. Ahuja HG, Felix CA, Aplan PD. 2000. Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations. Genes Chromosomes Cancer 29: 96-105.
4. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF. 2003. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72: 1117-1130.
5. Auckley DH, Crowell RE, Heaphy ER, Stidley CA, Lechner JF, Gilliland FD, Belinsky SA. 2001. Reduced DNA-dependent protein kinase activity is associated with lung cancer. Carcinogenesis 22: 723-727.
6. Burden DA, Goldsmith LJ, Sullivan DM. 1993. Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II. Biochem J 293: 297-304.
7. Chaung W, Mi LJ, Boorstein RJ. 1997. The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair. Nucleic Acids Res 25: 992-994.
8. Darroudi F, Natarajan AT. 1989. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II. Mutat Res 212: 137-148.
9. de Campos-Nebel M, Larripa I, González-Cid M. 2008. Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells. Mutat Res 646: 8-16.
10. de Campos-Nebel M, Larripa I, González-Cid M. 2010. Topoisomerase II-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombination. PLoS ONE 5: e12541.
11. Degrassi F, Fiore M, Palitti F. 2004. Chromosomal aberrations and genomic instability induced by topoisomerase-targeted antitumour drugs. Review. Curr Med Chem Anticancer Agents 4: 317-325.
12. Delacôte F, Han M, Stamato TD, Jasin M, Lopez BS. 2002. An xrcc4 defect or Wortmannin stimulates homologous recombination specifically induced by double-strand breaks in mammalian cells. Nucleic Acids Res 30: 3454-3463.
13. Delacôte F, Lopez BS. 2008. Importance of the cell cycle phase for the choice of the appropriate DSB repair pathway, for genome stability maintenance: The trans-S double-strand break repair model. Cell Cycle 7: 33-38.
14. Errami A, He DM, Fried AA, Overkamp WJ, Morolli B, Hendrickson EA, Eckardt-Schupp F, Oshimura M, Lohman PH, Jackson SP, Zdzienicka MZ. 1998. XR-C1, a new CHO cell mutant which is defective in DNA-PKcs, is impaired in both V(D)J coding and signal joint formation. Nucleic Acids Res 26: 3146-3153.
15. Ferguson DO, Sekiguchi JM, Chang S, Frank KM, Gao Y, DePinho RA, Alt FW. 2000. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci USA 97: 6630-6633.
16. Fortune JM, Osheroff N. 2000. Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice. Review. Prog Nucleic Acid Res Mol Biol 64: 221-253.
17. Frankenberg-Schwager M, Gebauer A, Koppe C, Wolf H, Pralle E, Frankenberg D. 2009. Single-strand annealing, conservative homologous recombination, nonhomologous DNA end joining, and the cell cycle-dependent repair of DNA double-strand breaks induced by sparsely or densely ionizing radiation. Radiat Res 171: 265-273.
18. Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, Chen ST, Wu HS, Wu PE, Shen CY. 2003. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: A multigenic study on cancer susceptibility. Cancer Res 63: 2440-2446.
19. Helleday T, Lo J, van Gent DC, Engelward BP. 2007. DNA double-strand break repair: From mechanistic understanding to cancer treatment. DNA Repair 6: 923-935.
20. Hu T, Miller CM, Ridder GM, Aardema MJ. 1999. Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: Implications for genotoxicity testing. Mutat Res 426: 51-62.
21. Huang X, Okafuji M, Traganos F, Luther E, Holden E, Darzynkiewicz Z. 2004. Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin. Cytometry A 58: 99-110.
22. Iliakis G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, Wu W, Guan J, Terzoudi G, Pantelias G. 2004. Mechanisms of DNA double strand break repair and chromosome aberration formation. Review. Cytogenet Genome Res 104: 14-20.
23. Iliakis G. 2009. Backup pathways of NHEJ in cells of higher eukaryotes: Cell cycle dependence. Review. Radiother Oncol 92: 310-315.
24. Jensen LH, Dejligbjerg M, Hansen LT, Grauslund M, Jensen PB, Sehested M. 2004. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells. BMC Pharmacol 4: 31.
25. Kanaar R, Hoeijmakers JH, van Gent DC. 1998. Molecular mechanisms of DNA double strand break repair. Review. Trends Cell Biol 8: 483-489.
26. Kato TA, Okayasu R, Bedford JS. 2009. Signatures of DNA double strand breaks produced in irradiated G1 and G2 cells persist into mitosis. J Cell Physiol 219: 760-765.
27. Kraakman-van der Zwet M, Overkamp WJ, van Lange RE, Essers J, van Duijn-Goedhart A, Wiggers I, Swaminathan S, van Buul PP, Errami A, Tan RT, Jaspers NG, Sharan SK, Kanaar R, Zdzienicka MZ. 2002. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol Cell Biol 22: 669-679.
28. Kuhfittig-Kulle S, Feldmann E, Odersky A, Kuliczkowska A, Goedecke W, Eggert A, Pfeiffer P. 2007. The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV. Mutagenesis 22: 217-233.
29. Larminat F, Germanier M, Papouli E, Defais M. 2002. Deficiency in BRCA2 leads to increase in non-conservative homologous recombination. Oncogene 21: 5188-5192.
30. Lee HS, Choe G, Park KU, Park do J, Yang HK, Lee BL, Kim WH. 2007. Altered expression of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) during gastric carcinogenesis and its clinical implications on gastric cancer. Int J Oncol 31: 859-866.
31. Lee SH, Kim CH. 2002. DNA-dependent protein kinase complex: A multifunctional protein in DNA repair and damage checkpoint. Review. Mol Cells 13: 159-166.
32. Leone G, Fianchi L, Pagano L, Voso MT. 2010. Incidence and susceptibility to therapy-related myeloid neoplasms. Chem Biol Interact 184: 39-45.
33. Lieber MR. 2008. The mechanism of human nonhomologous DNA end joining. Review. J Biol Chem 283: 1-5.
34. Mao Z, Bozzella M, Seluanov A, Gorbunova V. 2008. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle 7: 2902-2906.
35. McClendon AK, Osheroff N. 2007. DNA topoisomerase II, genotoxicity, and cancer. Mutat Res 623: 83-97.
36. Mosesso P, Darroudi F, van den Berg M, Vermeulen S, Palitti F, Natarajan AT. 1998. Induction of chromosomal aberrations (unstable and stable) by inhibitors of topoisomerase II, m-AMSA and VP16, using conventional Giemsa staining and chromosome painting techniques. Mutagenesis 13: 39-43.
37. Natarajan AT, Berni A, Marimuthu KM, Palitti F. 2008. The type and yield of ionising radiation induced chromosomal aberrations depend on the efficiency of different DSB repair pathways in mammalian cells. Mutat Res 642: 80-85.
38. Norppa H, Falck GC. 2003. What do human micronuclei contain? Mutagenesis 18: 221-233.
39. Peddi P, Loftin CW, Dickey JS, Hair JM, Burns KJ, Aziz K, Francisco DC, Panayiotidis MI, Sedelnikova OA, Bonner WM, Winters TA, Georgakilas AG. 2010. DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells. Free Radic Biol Med 48: 1435-1443.
40. Revaud D, Martins LM, Boussin FD, Sabatier L, Desmaze C. 2011. Different DNA-PKcs functions in the repair of radiation-induced and spontaneous DSBs within interstitial telomeric sequences. Chromosoma 120: 309-319.
41. Riches LC, Lynch AM, Gooderham NJ. 2008. Early events in the mammalian response to DNA double-strand breaks. Review. Mutagenesis 23: 331-339.
42. Rothkamm K, Krüger I, Thompson LH, Löbrich M. 2003. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 23: 5706-5715.
43. Saintigny Y, Delacôte F, Boucher D, Averbeck D, Lopez BS. 2007. XRCC4 in G1 suppresses homologous recombination in S/G2, in G1 checkpoint-defective cells. Oncogene 26: 2769-2780.
44. Saleh-Gohari N, Helleday T. 2004. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res 32: 3683-3688.
45. Shen H, Schultz M, Kruh GD, Tew KD. 1998. Increased expression of DNA-dependent protein kinase confers resistance to adriamycin. Biochim Biophys Acta 1381: 131-138.
46. Smart DJ, Halicka HD, Schmuck G, Traganos F, Darzynkiewicz Z, Williams GM. 2008. Assessment of DNA double-strand breaks and gammaH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone. Mutat Res 641: 43-47.
47. Tai YC, Domchek S, Parmigiani G, Chen S. 2007. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99: 1811-1814.
48. Takashima Y, Sakuraba M, Koizumi T, Sakamoto H, Hayashi M, Honma M. 2009. Dependence of DNA double strand break repair pathways on cell cycle phase in human lymphoblastoid cells. Environ Mol Mutagen 50: 815-822.
49. Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A, Takeda S. 1998. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J 17: 5497-5508.
50. Treszezamsky AD, Kachnic LA, Feng Z, Zhang J, Tokadjian C, Powell SN. 2007. BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II. Cancer Res 67: 7078-7081.
51. Turnbull C, Hodgson S. 2005. Genetic predisposition to cancer. Clin Med 5: 491-498.
52. Wang H, Zeng ZC, Bui TA, DiBiase SJ, Qin W, Xia F, Powell SN, Iliakis G. 2001. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res 61: 270-277.
53. Wang L, Roy SK, Eastmond DA. 2007. Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells. Mutat Res 616: 70-82.
54. Wilson PF, Hinz JM, Urbin SS, Nham PB, Thompson LH. 2010. Influence of homologous recombinational repair on cell survival and chromosomal aberration induction during the cell cycle in gamma-irradiated CHO cells. DNA Repair 9: 737-744.
55. Wu W, Wang M, Wu W, Singh SK, Mussfeldt T, Iliakis G. 2008. Repair of radiation induced DNA double strand breaks by backup NHEJ is enhanced in G2. DNA Repair 7: 329-338.